Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas J Donato

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Blood|October 25, 2011
Antileukemic effects of AMPK activators on BCR-ABL-expressing cellsEliza Vakana, Jessica K Altman, Heather Glaser, et al.
Oncotarget|February 22, 2021
Downregulation of SOX2 by inhibition of Usp9X induces apoptosis in melanomaHarish Potu, Malathi Kandarpa, Luke F Peterson, et al.
Biochemical Pharmacology|October 31, 2009
Targets and effectors of the cellular response to aurora kinase inhibitor MK-0457 (VX-680) in imatinib sensitive and resistant chronic myelogenous leukemiaNicholas J Donato, Dexing Fang, Hanshi Sun, et al.
Cancer Research|November 4, 2010
Deubiquitinase inhibition by small-molecule WP1130 triggers aggresome formation and tumor cell apoptosisVaibhav Kapuria, Luke F Peterson, Dexing Fang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2002
Superior therapeutic profile of poly-L-glutamic acid-paclitaxel copolymer compared with taxol in xenogeneic compartmental models of human ovarian carcinomaEdmond Auzenne, Nicholas J Donato, Chun Li, et al.
Oncotarget|July 2, 2014
Usp5 links suppression of p53 and FAS levels in melanoma to the BRAF pathwayHarish Potu, Luke F Peterson, Anupama Pal, et al.
Blood|January 2, 2003
BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571Nicholas J Donato, Ji Yuan Wu, Jonathan Stapley, et al.
Blood|February 1, 2008
Lyn regulates BCR-ABL and Gab2 tyrosine phosphorylation and c-Cbl protein stability in imatinib-resistant chronic myelogenous leukemia cellsJi Wu, Feng Meng, Henry Lu, et al.
Biochemical Pharmacology|May 31, 2011
Protein cross-linking as a novel mechanism of action of a ubiquitin-activating enzyme inhibitor with anti-tumor activityVaibhav Kapuria, Luke F Peterson, H D Hollis Showalter, et al.
Plos Pathogens|July 14, 2012
Antiviral activity of a small molecule deubiquitinase inhibitor occurs via induction of the unfolded protein responseJeffrey W Perry, Mohammad Ahmed, Kyeong-Ok Chang, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Blood|October 25, 2011
Antileukemic effects of AMPK activators on BCR-ABL-expressing cellsEliza Vakana, Jessica K Altman, Heather Glaser, et al.
Oncotarget|February 22, 2021
Downregulation of SOX2 by inhibition of Usp9X induces apoptosis in melanomaHarish Potu, Malathi Kandarpa, Luke F Peterson, et al.
Biochemical Pharmacology|October 31, 2009
Targets and effectors of the cellular response to aurora kinase inhibitor MK-0457 (VX-680) in imatinib sensitive and resistant chronic myelogenous leukemiaNicholas J Donato, Dexing Fang, Hanshi Sun, et al.
Cancer Research|November 4, 2010
Deubiquitinase inhibition by small-molecule WP1130 triggers aggresome formation and tumor cell apoptosisVaibhav Kapuria, Luke F Peterson, Dexing Fang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2002
Superior therapeutic profile of poly-L-glutamic acid-paclitaxel copolymer compared with taxol in xenogeneic compartmental models of human ovarian carcinomaEdmond Auzenne, Nicholas J Donato, Chun Li, et al.
Oncotarget|July 2, 2014
Usp5 links suppression of p53 and FAS levels in melanoma to the BRAF pathwayHarish Potu, Luke F Peterson, Anupama Pal, et al.
Blood|January 2, 2003
BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571Nicholas J Donato, Ji Yuan Wu, Jonathan Stapley, et al.
Blood|February 1, 2008
Lyn regulates BCR-ABL and Gab2 tyrosine phosphorylation and c-Cbl protein stability in imatinib-resistant chronic myelogenous leukemia cellsJi Wu, Feng Meng, Henry Lu, et al.
Biochemical Pharmacology|May 31, 2011
Protein cross-linking as a novel mechanism of action of a ubiquitin-activating enzyme inhibitor with anti-tumor activityVaibhav Kapuria, Luke F Peterson, H D Hollis Showalter, et al.
Plos Pathogens|July 14, 2012
Antiviral activity of a small molecule deubiquitinase inhibitor occurs via induction of the unfolded protein responseJeffrey W Perry, Mohammad Ahmed, Kyeong-Ok Chang, et al.
Pageof 4